Researchers have developed first-in-class drugs that…
0 reactions
Researchers have developed first-in-class drugs that simultaneously block HIF-1 and HIF-2, the "master regulators" of cancer progression. When paired with immunotherapy, these compounds eliminated tumors across four cancer types in mice by stripping away their low-oxygen defenses.
#science
#science
| 0 mlx | |
| 1 | |
| 0 |